title: Studying the enucleation process, DNA breakdown and telomerase activity of the K562 cell lines during erythroid differentiation in vitro.
abstract: During erythropoiesis, some organelles such as mitochondria and nucleus are lost by autophagy and enucleation processes in the presence of macrophages in vivo. In vitro production of erythrocytes has raised many questions about the mechanism of enucleation. The aim of this work was to study the DNA breakdown, enucleation, hemoglobin synthesis and telomerase activity of K562 cells during erythroid differentiation. For these purposes, K562 cells were induced to differentiate by erythropoietin + rhGM-CSF, DMSO, and sodium butyrate separately up to 14 d. In different time intervals, hemoglobin synthesis was evaluated by benzidine staining and RT-PCR for γ-globin gene expression. DNA breakdown was analyzed by 4',6-diamidino-2-phenylindole (DAPI) staining, DNA ladder electrophoresis and comet assay. The telomerase activity was evaluated by TRAP assay. Our result indicated that, sodium butyrate and DMSO inhibited K562 cell growth about 50-60% in comparison to untreated control cells. The percentage of benzidine-positive cells was about 45% in the presence of sodium butyrate after 10 d. Densitometric analysis of RT-PCR and calculated data indicated a 1.5-fold increase in relative γ-globin gene expression at 96 h, in the presence of 1 mM sodium butyrate in comparison with untreated cells. DAPI staining did not reveal any evidence of internal lysis of the nucleus during erythroid differentiation at first wk, but this was obvious in the second wk. DNA laddering pattern was not observed in differentiated cells during 14 d. In comet assay, the percentage of DNA in tail, tail length, and tail moment were significantly different between untreated and treated cells (p < 0.05). Telomerase activity was inhibited up to 90.3% during erythroid differentiation of these cells.
authors.affiliation: Department of Biochemistry, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran. deezagi@nigeb.ac.ir
authors.forename: Abdolkhaleg
authors.initials: A
authors.lastname: Deezagi
authors.forename: Mahkameh
authors.initials: M
authors.lastname: Abedi-Tashi
mesh_terms: D001973:Bromodeoxyuridine / Q000494:pharmacology; D002087:Butyrates / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D004249:DNA Damage / Q000187:drug effects; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D041905:Erythroid Cells / Q000166:cytology / Q000187:drug effects; D006454:Hemoglobins / Q000096:biosynthesis*; D006801:Humans; D020014:K562 Cells; D019098:Telomerase / Q000378:metabolism
chemical_list: D002087:Butyrates; D006454:Hemoglobins; D019098:Telomerase; D001973:Bromodeoxyuridine; D004121:Dimethyl Sulfoxide